MedTrace Logo

Clinical and Immunological Evaluation of HA in Treatment of Periodontitis

NCT06324474 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-12-05

No results posted yet for this study

Summary

To evaluate the immunological effectiveness of Hyaluronic acid as adjunction treatment to scaling and root planning and scaling and root planning alone.

Comparison between clinical measurement before and after treatment. Evaluate the level of IGF-1 in treated site as immunological marker if periodontal regeneration.

Conditions

  • Periodontitis

Interventions

DRUG

Hyaluronic acid

Gengigel syringe containing 1ml of 0.8% HA

BEHAVIORAL

scaling and root planning

scaling and root planning using ultrasonic scaler

Sponsors & Collaborators

  • Sana'a University

    lead OTHER

Principal Investigators

  • Ghada Almuqayad, BDS · Sana'a University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2025-12-12
Completion
2025-12-12

Countries

  • Yemen

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06324474 on ClinicalTrials.gov